Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Pair Echo With Right Heart Catheterization in PH: Anjali Vaidya, MD Anjali Vaidya, MD, FACC, FASE, FACP

Published Date: 27 Oct 2026

Anjali Vaidya, MD, explains why echocardiography should inform right heart catheterization interpretation in pulmonary hypertension at CHEST 2026.

New Trials Favor PE Intervention in Sicker Intermediate-Risk Patients Samantha Pettigrew, MD

Published Date: 27 Oct 2026

Samantha Pettigrew, MD, reviews HI-PEITHO, PRAGUE-26, and PEERLESS and how they shape intervention choices in intermediate-risk PE at CHEST 2026.

CAR-T Agent Zola-cel Shows No New Multiple Sclerosis Disease Activity in Phase 1 Study Louie Pasculli

Published Date: 27 Oct 2026

Updated data from Breakfree-2 study showed that treatment with a single zola-cel infusion achieved NEDA-3 in highly active relapsing multiple sclerosis and led to mostly stable disability in progressive multiple sclerosis.

Remibrutinib Lowers Relapse Rate vs Teriflunomide in Relapsing MS Matt Hoffman, Louie Pasculli

Published Date: 27 Oct 2026

Phase 3 data show the oral BTK inhibitor reduced annualized relapse rate by 35.2% and 31.2% vs teriflunomide, with no liver safety signal or Hy's Law cases.

Houston Forum Highlights Awareness Gaps in NF1 Plexiform Neurofibroma Care Marco Meglio

Published Date: 27 Oct 2026

At a NeurologyLive and Targeted Oncology Clinical Forum in Houston, Kevin J. Bielamowicz, MD, of Arkansas Children’s Hospital, discussed how incidental diagnosis and limited awareness of systemic therapy continue to delay care for patients with NF1-associated plexiform neurofibromas.

Tenecteplase Benefit Before Thrombectomy Varies by Stroke Cause, Study Shows Marco Meglio

Published Date: 27 Oct 2026

A secondary analysis of the BRIDGE-TNK trial found tenecteplase before thrombectomy improved functional outcomes in cardioembolic but not atherosclerotic stroke.

NeurologyLive® Brain Games: October 25, 2026 Louie Pasculli, Marco Meglio

Published Date: 27 Oct 2026

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is recent advances in gene therapies.

Interpreting Kidney Donor Pregnancy Signals, With Amit Garg, MD, PhD Amit X. Garg, MD, PhD

Published Date: 27 Oct 2026

Chance, biology, and shared genetics may explain more small for gestational age births after living kidney donation.

Pentoxifylline in Diabetic Kidney Disease: What the Evidence Shows Rajiv Agarwal, MD, MS

Published Date: 27 Oct 2026

Rajiv Agarwal, MD, MS, explains why decades of pentoxifylline data in DKD remain inconclusive and how the VA PTXRx trial aims to settle the question.

Does CKD Require Restricting Potassium-Rich Foods? With Navdeep Tangri, MD Navdeep Tangri, MD

Published Date: 27 Oct 2026

In a randomized crossover trial, a liberalized produce diet raised urinary potassium excretion without changing serum potassium.

Knowledge Hub

Oncology

Cancer Treatment Tolerance in Very Old Adults

An evidence-based review of treatment tolerance, geriatric assessment, risks, management, and emerging therapies for adults aged 80 years and older with cancer.

Oncology

Long-Read Sequencing of Complex Tumor Genomes

A clinical review of how long-read sequencing resolves complex tumor genomes, improves diagnosis, identifies resistance mechanisms, and supports precision cancer treatment.

Oncology

Cancer Enhancer Rewiring and Tumor Cell Identity

A medical review of how enhancer rewiring reshapes tumor cell identity, cancer plasticity, diagnosis, treatment resistance, and emerging therapeutic strategies.

Oncology

Tumor-Associated Stroma Regeneration Models

A medical review of tumor-associated stroma regeneration models, their biological mechanisms, clinical relevance, emerging therapies, and research standards.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Pair Echo With Right Heart Catheterization in PH: Anjali Vaidya, MD Anjali Vaidya, MD, FACC, FASE, FACP

New Trials Favor PE Intervention in Sicker Intermediate-Risk Patients Samantha Pettigrew, MD

CAR-T Agent Zola-cel Shows No New Multiple Sclerosis Disease Activity in Phase 1 Study Louie Pasculli

Remibrutinib Lowers Relapse Rate vs Teriflunomide in Relapsing MS Matt Hoffman, Louie Pasculli

Houston Forum Highlights Awareness Gaps in NF1 Plexiform Neurofibroma Care Marco Meglio

Tenecteplase Benefit Before Thrombectomy Varies by Stroke Cause, Study Shows Marco Meglio

NeurologyLive® Brain Games: October 25, 2026 Louie Pasculli, Marco Meglio

Interpreting Kidney Donor Pregnancy Signals, With Amit Garg, MD, PhD Amit X. Garg, MD, PhD

Pentoxifylline in Diabetic Kidney Disease: What the Evidence Shows Rajiv Agarwal, MD, MS

Does CKD Require Restricting Potassium-Rich Foods? With Navdeep Tangri, MD Navdeep Tangri, MD

Knowledge Hub

Cancer Treatment Tolerance in Very Old Adults

Long-Read Sequencing of Complex Tumor Genomes

Cancer Enhancer Rewiring and Tumor Cell Identity

Tumor-Associated Stroma Regeneration Models

Managing Treatment Transitions During Cancer Care

Preventing Cancer-Related Cachexia Through Early Metabolic Intervention

Delayed Neurotoxicity After Cancer Treatment: Mechanisms, Clinical Features, and Management

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Pair Echo With Right Heart Catheterization in PH: Anjali Vaidya, MD Anjali Vaidya, MD, FACC, FASE, FACP

New Trials Favor PE Intervention in Sicker Intermediate-Risk Patients Samantha Pettigrew, MD

CAR-T Agent Zola-cel Shows No New Multiple Sclerosis Disease Activity in Phase 1 Study Louie Pasculli

Remibrutinib Lowers Relapse Rate vs Teriflunomide in Relapsing MS Matt Hoffman, Louie Pasculli

Houston Forum Highlights Awareness Gaps in NF1 Plexiform Neurofibroma Care Marco Meglio

Tenecteplase Benefit Before Thrombectomy Varies by Stroke Cause, Study Shows Marco Meglio

NeurologyLive® Brain Games: October 25, 2026 Louie Pasculli, Marco Meglio

Interpreting Kidney Donor Pregnancy Signals, With Amit Garg, MD, PhD Amit X. Garg, MD, PhD

Pentoxifylline in Diabetic Kidney Disease: What the Evidence Shows Rajiv Agarwal, MD, MS

Does CKD Require Restricting Potassium-Rich Foods? With Navdeep Tangri, MD Navdeep Tangri, MD

Knowledge Hub

Cancer Treatment Tolerance in Very Old Adults

Long-Read Sequencing of Complex Tumor Genomes

Cancer Enhancer Rewiring and Tumor Cell Identity

Tumor-Associated Stroma Regeneration Models

Managing Treatment Transitions During Cancer Care

Preventing Cancer-Related Cachexia Through Early Metabolic Intervention

Delayed Neurotoxicity After Cancer Treatment: Mechanisms, Clinical Features, and Management

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views